First Hawaiian Bank Abbott Laboratories Transaction History

First Hawaiian Bank

$3.01 Billion
Q4 2024

A detailed history of First Hawaiian Bank transactions in Abbott Laboratories stock. As of the latest transaction made, First Hawaiian Bank holds 15,921 shares of ABT stock, worth $1.79 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

15,921

Previous 16,141 1.36%

Holding current value

$1.79 Million

Previous $1.84 Million 2.17%

% of portfolio

0.06%

Previous 0.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 08, 2025	SELL	$111.93 - $119.39 $24,624 - $26,265	-220 Reduced 1.36%	15,921 $1.8 Million
Q3 2024 Oct 04, 2024	SELL	$100.07 - $118.13 $272,790 - $322,022	-2,726 Reduced 14.45%	16,141 $1.84 Million
Q2 2024 Jul 02, 2024	SELL	$100.73 - $112.44 $91,160 - $101,758	-905 Reduced 4.58%	18,867 $1.96 Million
Q1 2024 Apr 05, 2024	BUY	$109.52 - $120.96 $2,518 - $2,782	23 Added 0.12%	19,772 $2.25 Million
Q4 2023 Jan 08, 2024	BUY	$90.19 - $110.4 $378,527 - $463,348	4,197 Added 26.99%	19,749 $2.17 Million
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $603,176 - $723,710	-6,314 Reduced 28.88%	15,552 $1.51 Million
Q2 2023 Jul 06, 2023	SELL	$100.78 - $112.29 $152,984 - $170,456	-1,518 Reduced 6.49%	21,866 $2.38 Million
Q1 2023 Apr 18, 2023	SELL	$96.86 - $114.01 $166,986 - $196,553	-1,724 Reduced 6.87%	23,384 $2.37 Million
Q4 2022 Jan 12, 2023	SELL	$95.06 - $111.52 $335,561 - $393,665	-3,530 Reduced 12.33%	25,108 $2.76 Million
Q3 2022 Oct 05, 2022	SELL	$96.76 - $112.03 $236,674 - $274,025	-2,446 Reduced 7.87%	28,638 $2.77 Million
Q2 2022 Jul 22, 2022	SELL	$102.07 - $123.37 $1.16 Million - $1.4 Million	-11,356 Reduced 26.76%	31,084 $3.38 Million
Q1 2022 Apr 06, 2022	SELL	$114.02 - $139.04 $162,022 - $197,575	-1,421 Reduced 3.24%	42,440 $5.02 Million
Q4 2021 Jan 12, 2022	BUY	$115.53 - $141.46 $529,589 - $648,452	4,584 Added 11.67%	43,861 $6.17 Million
Q3 2021 Oct 12, 2021	SELL	$116.66 - $129.06 $1.42 Million - $1.57 Million	-12,171 Reduced 23.66%	39,277 $4.64 Million
Q2 2021 Jul 08, 2021	BUY	$105.79 - $124.53 $294,201 - $346,317	2,781 Added 5.71%	51,448 $5.96 Million
Q1 2021 Apr 09, 2021	SELL	$108.84 - $128.23 $439,495 - $517,792	-4,038 Reduced 7.66%	48,667 $5.83 Million
Q4 2020 Jan 12, 2021	BUY	$105.0 - $114.42 $236,460 - $257,673	2,252 Added 4.46%	52,705 $5.77 Million
Q3 2020 Oct 06, 2020	SELL	$91.64 - $111.29 $604,732 - $734,402	-6,599 Reduced 11.57%	50,453 $5.49 Million
Q2 2020 Aug 05, 2020	BUY	$76.57 - $98.0 $1.57 Million - $2 Million	20,443 Added 55.84%	57,052 $5.22 Million
Q1 2020 Apr 21, 2020	BUY	$62.82 - $91.86 $22,803 - $33,345	363 Added 1.0%	36,609 $2.89 Million
Q4 2019 Jan 13, 2020	SELL	$78.51 - $87.4 $1,805 - $2,010	-23 Reduced 0.06%	36,246 $3.15 Million
Q3 2019 Oct 03, 2019	SELL	$81.84 - $88.74 $2,700 - $2,928	-33 Reduced 0.09%	36,269 $3.03 Million
Q2 2019 Jul 15, 2019	SELL	$72.88 - $85.0 $364 - $425	-5 Reduced 0.01%	36,302 $3.05 Million
Q1 2019 Apr 02, 2019	SELL	$66.22 - $80.06 $4,039 - $4,883	-61 Reduced 0.17%	36,307 $2.9 Million
Q4 2018 Jan 11, 2019	BUY	$65.56 - $74.27 $396,179 - $448,813	6,043 Added 19.93%	36,368 $2.63 Million
Q3 2018 Oct 16, 2018	BUY	$60.81 - $73.36 $993,392 - $1.2 Million	16,336 Added 116.78%	30,325 $2.23 Million
Q2 2018 Jul 20, 2018	BUY	$57.57 - $63.54 $26,021 - $28,720	452 Added 3.34%	13,989 $854,000
Q1 2018 Apr 12, 2018	SELL	$56.27 - $63.62 $12,942 - $14,632	-230 Reduced 1.67%	13,537 $810,000
Q4 2017 Jan 16, 2018	BUY	$53.68 - $57.47 $1,932 - $2,068	36 Added 0.26%	13,767 $786,000
Q3 2017 Oct 19, 2017	BUY	$48.06 - $53.64 $659,911 - $736,530	13,731	13,731 $732,000

Others Institutions Holding ABT

# of Institutions

3,189

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Hawaiian Bank with notifications on news.

Account

First Hawaiian Bank Abbott Laboratories Transaction History